文献速递眼底病与葡萄膜炎

1型黄斑新生血管形态对经抗VEGF治疗患者黄斑萎缩进展的影响

IMPLICATIONS OF THE MORPHOLOGIC PATTERNS OF TYPE 1 MACULAR NEOVASCULARIZATION ON MACULAR ATROPHY GROWTH ON PATIENTS UNDER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT.
PubMed 文献 · Retina · 2021-01-01

该回顾性研究纳入20例接受长期抗VEGF治疗的渗出性新生血管性年龄相关性黄斑变性患者,评估黄斑萎缩进展与1型黄斑新生血管形态的对应关系。结果显示,持续存在未成熟血流模式的ETDRS分区,其黄斑萎缩增长率低于成熟血流模式分区(P = 0.001)。结论提示,OCT血管成像上未成熟血流模式与较低的黄斑萎缩进展速率相关。

要点

  • 持续未成熟血流模式的ETDRS分区黄斑萎缩增长率低于成熟模式分区(P = 0.001)。
  • 研究纳入20眼,中位随访1.85年,中位抗VEGF注射频率为4.0次/年。
  • 黄斑新生血管形态通过扫频源OCT血管成像评估,黄斑萎缩基于SD-OCT、en-face近红外和眼底自发荧光评估。

核心结论

  • OCT血管成像上存在未成熟血流模式与较低的黄斑萎缩进展速率相关。

研究设计与样本

  • 回顾性研究,纳入20例患者20眼,均存在覆盖或邻近黄斑新生血管的完全性视网膜色素上皮和外层视网膜萎缩。
  • 黄斑萎缩评估基于谱域OCT、en-face近红外成像和眼底自发荧光;黄斑新生血管血流形态通过扫频源OCT血管成像评估。
  • 按ETDRS分区对血流形态进行定性分类为未成熟、成熟和超成熟模式,并设计MATLAB自动分析计算各分区黄斑萎缩面积。

主要发现

  • 共纳入20眼,平均年龄85.4(8.3)岁,中位随访1.85(1.0-2.4)年,中位抗VEGF注射频率为4.0(2.0-5.0)次/年。
  • 随访期间,持续存在未成熟血流模式的ETDRS分区黄斑萎缩增长率低于成熟黄斑新生血管血流模式分区(P = 0.001)。

临床怎么用

  • 在长期抗VEGF治疗中,可通过OCT血管成像识别1型黄斑新生血管的血流形态模式,未成熟模式可能提示黄斑萎缩进展较慢。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the correspondence between macular atrophy (MA) progression and Type 1 macular neovascularization morphology during long-term anti-vascular endothelial growth factor treatment for exudative neovascular age-related macular degeneration. METHODS: Retrospective review of consecutive patients with complete retinal pigment epithelium and outer retina atrophy overlying or in the proximity of macular neovascularization. The assessment of MA was based on spectral domain optical coherence tomography, en-face near infra-red imaging and fundus autofluorescence. Macular neovascularization blood flow morphology was evaluated by swept-source optical coherence tomography-angiography. Qualitative features were categorized per ETDRS sector as: immature, mature; and hypermature pattern. An automatic analysis was designed in MATLAB coding language to compute MA per ETDRS. Measurements were compared between the baseline and the last follow-up visit. RESULTS: Twenty eyes from 20 patients were included; the mean age was 85.4 (8.3) years. The median follow-up was 1.85 (1.0-2.4) years and the median anti-vascular endothelial growth factor injection rate during follow-up was 4.0 (2.0-5.0) injections/year. During follow-up, sectors with persistence of an immature blood flow pattern had a lower MA growth rate than sectors with mature macular neovascularization flow patterns (P = 0.001). CONCLUSION: The presence of an immature blood flow pattern on optical coherence tomography-angiography is associated with a lower progression rate of MA.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Cabral D, Coscas F, Pereira T, et al. IMPLICATIONS OF THE MORPHOLOGIC PATTERNS OF TYPE 1 MACULAR NEOVASCULARIZATION ON MACULAR ATROPHY GROWTH ON PATIENTS UNDER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT. Retina. 2021. PMID: 32355125. doi:10.1097/IAE.0000000000002842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。